HF
BBC icon

HRT Financial’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

HRT Financial’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,085
Closed -$234K – 3788
2025
Q4 		$234K Buy
+6,085
New +$207K ﹤0.01% 2537

Other funds holding BBC

KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $454M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
APW
Aurora Private Wealth Rockaway, New Jersey $140M AUM
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial's BBC Position: Q1 2026 in Review

HRT Financial sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q1 2026, closing a stake of 6,085 shares — an estimated $234K sold.

HRT Financial first reported a position in BBC in Q4 2025 and held it in 1 quarter. The position peaked at $234K in Q4 2025. 20 funds tracked by Wall St. Rank hold BBC as of Q1 2026.

  • HRT Financial reported no remaining Virtus Biotech Clinical Trials ETF position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 6,085 Virtus Biotech Clinical Trials ETF shares in Q1 2026, an estimated $234K.
  • HRT Financial first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2025 and held it in 1 quarter.
  • HRT Financial's Virtus Biotech Clinical Trials ETF position peaked at $234K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.